great news..
also from bioshares on sat just passed ..
"the ACS market in the US for heparin products is estimated at $500m".
If you add in the "normal" heparin market you have an enormous potential market for ACL. Bioshares also pointed out that the recent apparent fall in Arixtra sales was not in fact a fall at all.
Put all this together with acl's freedom to do a new deal in the US and we may actually see something quicker than we thought .. equally this makes acl at 60 odd cents an extremely attractive target..
my opinion only
- Forums
- ASX - By Stock
- great arixtra news
great news.. also from bioshares on sat just passed .."the ACS...
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online